Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...
INDIANAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Today Eli Lilly and Company (NYSE: LLY) announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the ...
Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...
Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients: Indianapolis Wednesday, February 26, 2025, 17:00 Hrs [IST] Eli Lilly and Company announ ...
To learn more about the Zepbound single-dose vial, please visit Zepbound.lilly.com. To learn more about LillyDirect, please visit LillyDirect.lilly.com. About Zepbound (tirzepatide) injection Zepbound ...
The drugmaker will now offer 7.5mg and 10mg doses of Zepbound, which uses the active ingredient tirzepatide, in single-dose vials. The medications are available for $499 during a patient’s first month ...